
Dalmia Bharat Q1 Results FY26: Q1 PAT Jumps 178.72% to ₹393.00 crore; Revenue Surged 0.41% YoY
Dalmia Bharat Q1 Results FY26
Updated: 23 Jul 2025 • 1:53 pm
Posted by:

Dalmia Bharat Q1 Results 2025: Extracts of FY25 & FY26 (Consolidated Figures)
| Particulars | Quarter Ended | |
| 30-06-2025 | 30-06-2024 | |
| Revenue from Operations | ₹3,636.00 | ₹3,621.00 |
| Profit Before Tax (PBT) | ₹932.00 | ₹719.00 |
| Profit After Tax (PAT) | ₹393.00 | ₹141.00 |
(Figures in crore)
Dalmia Bharat Q1 Results 2025: Extracts of FY25 & FY26 (Standalone Figures)
| Particulars | Quarter Ended | |
| 30-06-2025 | 30-06-2024 | |
| Revenue from Operations | ₹75.00 | ₹34.00 |
| Profit Before Tax (PBT) | ₹38.00 | ₹103.00 |
| Profit After Tax (PAT) | ₹33.00 | ₹96.00 |
(Figures in crore)
Dalmia Bharat Q1 Results 2026 Highlights – (Q1 vs FY25)
- Dalmia Bharat clocked Q1 FY26 consolidated revenue of ₹3,636.00 crores vs ₹3,621.00 crores.
- On the profit front, Dalmia Bharat earned a consolidated PAT of ₹393.00 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹141.00 crores.
- Consolidated PAT is down for the first quarter of FY26, was 178.72% YoY, and revenue growth was 0.41% YoY.
- As per the standalone figures, quarterly PAT of Dalmia Bharat is down 65.63% and revenue is up by 120.59% YoY.
Dalmia Bharat Share Price Performance
On the opening bell of 23rd July 2025, the shares of Dalmia Bharat opened at ₹2,325.10 per share. However, the initial gains are sustained as of now, and Dalmia Bharat shares are trading at ₹2,243.50 per share, higher than their opening price.
Considering the long-term performance, Dalmia Bharat shares have yielded close to 26.21% returns in the past 1-year, and 5-year returns stand at 216.61%. Over the maximum timeframe, the Dalmia Bharat share provided 125.46% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in Dalmia Bharat shares after thorough research.
For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Also Read : Ceat Q1 Results FY26: Q1 PAT Dropped 27.06% to ₹112.45 crore; Revenue Rose 10.54% YoY
Recent Articles
IRFC Q1 Results FY26: Q1 PAT Jumps 10.71% to ₹1,745.69 crore; Revenue Surged 2.21% YoY
GNG Electronics IPO GMP: Day 1 IPO Live Updates
Indiqube Spaces IPO GMP: Day 1 IPO Live Updates
TSC India IPO GMP: Day 1 IPO Live Updates
Kajaria Ceramics Q1 Results FY26: Q1 PAT Jumps 21.33% to ₹108.98 crore; Revenue Surged 0.63% YoY
GNG Electronics IPO GMP & Review: Apply or Avoid?
Oberio Realty Ltd Q1 Results FY26: Q1 PAT Down 27.93% to ₹421.25 crore; Revenue Fell 29.72% YoY
DCM Shriram Q1 Results FY26: Q1 PAT Surged 13.04% to ₹113.38 crore; Revenue Rose 12.44% YoY
Recent Articles

Jindal Photo Share Price Target 2026 Analyst Forecast Bull and Bear Case
24 June 2026

Lincoln Pharmaceuticals Share Price Target 2026 Analyst Forecast Bull and Bear Case
24 June 2026

Nifty IT Rises Despite JPMorgan Warning of AI Disruption; Infosys, Tech Mahindra Gain, HCLTech and Wipro Lag
24 June 2026

Lotus Eye Hospital and Institute Share Price Target 2026 Analyst Forecast Bull and Bear Case
24 June 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Jindal Photo Share Price Target 2026 Analyst Forecast Bull and Bear Case
Lincoln Pharmaceuticals Share Price Target 2026 Analyst Forecast Bull and Bear Case
Nifty IT Rises Despite JPMorgan Warning of AI Disruption; Infosys, Tech Mahindra Gain, HCLTech and Wipro Lag
Lotus Eye Hospital and Institute Share Price Target 2026 Analyst Forecast Bull and Bear Case
Liberty Shoes Share Price Target 2026 Analyst Forecast Bull and Bear Case
Popular this week
Jindal Photo Share Price Target 2026 Analyst Forecast Bull and Bear Case
Lincoln Pharmaceuticals Share Price Target 2026 Analyst Forecast Bull and Bear Case
Nifty IT Rises Despite JPMorgan Warning of AI Disruption; Infosys, Tech Mahindra Gain, HCLTech and Wipro Lag
Lotus Eye Hospital and Institute Share Price Target 2026 Analyst Forecast Bull and Bear Case
Liberty Shoes Share Price Target 2026 Analyst Forecast Bull and Bear Case

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





